Skip to main content

Market Overview

Geron Corp Ticks Higher On Patient News (GERN)

Benzinga Staff

April 07, 2011 9:47am Comments

Geron Corp (NASDAQ: GERN) ticks higher on circulating information that the company's first stem cell therapy patient has come forward.

Information can be found here from The Washington Post.

© 2025 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.

View Comments and Join the Discussion!

View the discussion thread.

Posted-In: The Washington Post Rumors FDA Legal

1	Another Fed Official Backs A Rate Cut—Goldman Sees Trouble Ahead If The Fed Waits
2	YELP, MDU: Earnings Scheduled For August 7, 2025
3	SNAP, ANET: Wall Street Recovers, Apple Rallies 6% On $100-Billion Gov Ma...
4	AMD, Z: Apple Jumps, Eli Lilly Crashes On Worst Day In 25 Years...
5	NVO, LLY: Eli Lilly's Closely Watched Obesity Pill O...
6	LLY: Eli Lilly Co. Q2 FY2025 Earnings Transcript
7	LLY, XYZ: Nasdaq Surges Over 1% Amid Jump In A...

1	F: Ford Delays Plans For Electric Pickup, Van to 2028 Amid Affordable EV Push Due...
2	SRTS, ISPC: Why Expedia Shares Are Trading Higher By Around 18%; Here Are 20 Stoc...
3	TSLA: Steve Bannon Eyes 2028 Presidential Run, Feels JD Vance 'Not...
4	SOUN: SoundHound AI Stock Surges 20% Premarket After Record Q2 Reve...
5	SRDX, EMA: Earnings Scheduled For August 8, 2025
6	GLD, DBP: US Imposes Tariffs On Swiss Gold Imports, Th...
7	JPMorgan Now Expects September Fed Cut Inste...